Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall S
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.21 per share a year ago.
CVS Health Corp (NYSE:CVS) shares jumped 10.5% pre-market in what may have been a reaction to the US presidential election results, as the drugstore and healthcare services provider reported mixed t
CVS's stock surges after revenue rose well above expectations, while profit missed because of a large charge premium deficiency reserves charge.
Third-quarter adjusted earnings per share was $1.09, confirming preliminary numbers from October. A Trump victory is also seen as beneficial as it's likely to benefit Medicare Advantage players.
CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising medical costs in the third quarter caused the company to preannounce an earnin
CVS Health reported mixed third-quarter results as higher medical costs squeezed its bottom line. The company expects elevated medical costs to continue to pressure its performance this year, "and as
New CVS Health chief executive officer David Joyner promoted an internal executive, Prem Shah, as group president of the company and hired former UnitedHealth Group executive Steve Nelson to run Aetna

CVS Health Announces Leadership Appointments

06:30am, Wednesday, 06'th Nov 2024
Prem Shah named Group President, CVS Health; Steve Nelson named President, Aetna WOONSOCKET, R.I. , Nov. 6, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced Prem Shah will be Group Presiden
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior year Third quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09 Third quarter GAAP di
Smaller pharmacies are accusing GoodRx and CVS of colluding to suppress generic prescription drug reimbursements. As Reuters reported Tuesday (Nov. 5), drug coupon aggregator GoodRx and a pair o
Steve Grasso, CEO of Grasso Global, joins CNBC's 'The Exchange' to discuss outlooks on three stocks: Supermicro, Novo Nordisk, and CVS Health.
Health insurers have been getting a lot of heat surrounding the rising costs of Medicare Advantage (MA) plans. Companies like CVS Health Co. NYSE: CVS have seen their medical benefits ratio (MBR) cont
CVS Health's David Joyner is expected to address how he will better manage rising patient costs in the Medicare business than his predecessor when he tackles his first earnings call as CEO on Wednesda
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE